首页> 外文期刊>International Urology and Nephrology >Prognostic significance of tumor location and superficial urothelial bladder carcinoma history in patients with ureteral urothelial carcinoma treated with radical nephroureterectomy.
【24h】

Prognostic significance of tumor location and superficial urothelial bladder carcinoma history in patients with ureteral urothelial carcinoma treated with radical nephroureterectomy.

机译:根治性肾切除术治疗输尿管尿路上皮癌患者的肿瘤位置和浅表尿路上皮膀胱癌病史的预后意义。

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the significance of tumor location and superficial urothelial bladder carcinoma (UBC) history on oncological outcomes in patients treated with radical nephroureterectomy (RNU) for ureteral urothelial carcinoma (UC).One hundred and thirty-two patients treated with RNU for ureteral UC between January 1999 and July 2010 were retrospectively analyzed. Recurrence probabilities and survival rates were analyzed, stratified by tumor location and superficial UBC history.Comparison of patients with proximal, middle, and distal ureteral UC showed that percentage of bladder recurrence was 13.3, 14.7, and 25.0 %, respectively (P = 0.285); retroperitoneal (tumor bed or lymph node) recurrence was 26.7, 14.7, and 27.9 % (P = 0.319); and contralateral recurrence was 0, 2.9, and 0 % (P = 0.234). Comparison of patients with and without history of superficial UBC revealed that percentage of bladder recurrence was 15.4 and 20.2 %, respectively (P = 0.681); retroperitoneal recurrence was 15.4 and 25.2 % (P = 0.433); and contralateral recurrence was 0 and 0.84 % (P = 0.740). Using multivariable Cox regression analyses, there were no significant differences of recurrence-free survival (RFS) and cancer-specific survival (CSS) with regard to neither tumor location nor superficial UBC history (RFS: P = 0.282 and 0.762, CSS: P = 0.272 and 0.818, respectively).Tumor location and history of superficial UBC could not be used to predict oncological outcomes of patients who underwent RNU for ureteral UC. Therefore, operative strategies or postoperative surveillance should not be affected by tumor location or history of superficial UBC.
机译:目的探讨根治性肾结直肠癌切除术(RNU)治疗输尿管上皮癌(UC)患者的肿瘤位置和浅表尿路上皮膀胱癌(UBC)历史对肿瘤学结局的意义.RNU治疗的132例患者之间回顾性分析了1999年1月和2010年7月。根据肿瘤部位和浅表UBC病史对复发概率和存活率进行了分析。比较近端,中段和远端输尿管UC患者的膀胱复发百分比分别为13.3%,14.7%和25.0%(P = 0.285) ;腹膜后(肿瘤床或淋巴结)复发率为26.7%,14.7%和27.9%(P = 0.319);对侧复发率分别为0、2.9和0%(P = 0.234)。比较有无浅表UBC病史的患者,发现膀胱复发的百分比分别为15.4和20.2%(P = 0.681)。腹膜后复发率分别为15.4和25.2%(P = 0.433);对侧复发率分别为0和0.84%(P = 0.740)。使用多变量Cox回归分析,无论是肿瘤位置还是浅表UBC病史,无复发生存期(RFS)和癌症特异性生存期(CSS)均无显着差异(RFS:P = 0.282和0.762,CSS:P =分别为0.272和0.818)。浅表UBC的肿瘤位置和历史不能用于预测接受RNU输尿管UC的患者的肿瘤学结局。因此,手术策略或术后监测不应受肿瘤部位或浅表UBC史的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号